et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP study group).
Abbondanzo SL, et al. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas. Am J Pathol 1998;153:1969 -76. 17. Weisenburger DD, Armitage JO. Mantle cell lymphoma-an entity comes of age. Blood 1996;87:4483-94. 18. Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1negative MCL-like B-cell lymphoma. Blood 2000;95:2253-61. 19. Remstein ED, Buno I, Bailey R, Kurtin PJ, Proffitt J, Dewald GW. Diagnostic utility of fluorescence in situ hybridization (FISH) versus polymerase chain reaction (PCR) in mantle cell lymphoma [abstract 943]. Mod Pathol 2000;13:161A. 20. Vaandrager J-W, Schuuring E, Zwikstra E, de Boer CJ, Kleiverda KK, van Krieken JH, et al. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86 -96. 24. Brynes RK, McCourty A, Tamayo R, Jenkins K, Battifora H. Demonstration of cyclin D1 (Bcl-1) in mantle cell lymphoma. Enhanced staining using heat and ultrasound epitope retrieval. Appl Immunohistochem 1997;5:45-8. 25. Caraway NP, Medeiros LJ, Gu J, Luthra R, Romaguera J, Katz RL. Utility of fluorescence in-situ hybridization (FISH) to detect cyclin D1 breakpoints in staging peripheral blood (PB) and bone marrow (BM) specimens of patients with mantle cell lymphoma (MCL) negative by PCR for MTC bcl-1/JH DNA fusion sequences [abstract #840]. Mod Pathol 2000;13:144A. 26. Bosch F, Campo E, Jares P, Pittaluga S, Muñoz J, Nayach I, et al. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukemia. Br J Haematol 1995;91:1025-30. 27. Lai R, Medeiros LJ, Wilson CS, Sun NC, Koo C, McCourty A, et al. Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation with cyclin-D1 immunoreactivity. Mod Pathol 1998;11: 642-7. 28. Jadayel D, Matutes E, Dyer MJ, Brito-Babapulle V, Khohkar MT, Oscier D, et al. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. Blood 1994;83:3664 -71. 29. Savilo E, Campo E, Mollejo M, Pinyol M, Piris MA, Zukerberg LR, et al. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.As astutely pointed out by the authors in the preface, the pathology of the gallbladder, biliary tract, and pancreas is an area that has few dedicated monographs. This text provides a comprehensive overview of the region. As many surgical pathologists will attest, a scheduled Whipple procedure sends one scrambling for texts dedicated to this subject. The widespread use of this procedure as well as endoscopic techniques ensure that the pathologist must be adequately prepared to interpret tissue specimens from this region. Not to mislea...
Lymphocytic mastitis and diabetic mastopathy are uncommon fibroinflammatory breast diseases. The lesions seen in these entities are unique in that the associated lymphoid infiltrates are composed of predominantly B cells. In addition, B-cell lymphoepithelial lesions, a finding commonly associated with extranodal marginal zone B-cell/mucosaassociated lymphoid tissue (MALT) lymphomas, are also often present in lymphocytic mastitis and diabetic mastopathy. Although the clinical and immunomorphologic features are well characterized, the clonality of the B-cell infiltrate and the lymphomatous potential of lymphocytic mastitis and diabetic mastopathy have not been emphasized in the literature. We evaluated 11 cases of lymphocytic mastitis/diabetic mastopathy for immunoglobulin heavy chain gene rearrangement and correlated the findings with all available clinical data. A longstanding history of Type I diabetes mellitus was present in seven patients. One nondiabetic patient had Sjogren's syndrome, and two patients had no history of diabetes mellitus or other autoimmune disease. Clinical data were unavailable for one patient. B-cell-predominant lymphoid infiltrates were seen in all cases, and B-cell lymphoepithelial lesions were found in five. No evidence of a B-cell clone was found in any of the 11 cases by appropriately controlled immunoglobulin heavy chain gene rearrangement studies, and none of the patients developed lymphoma during follow-up intervals ranging from 2-126 months. These findings suggest that despite the presence of B-cell-predominant lymphoid infiltrates and lymphoepithelial lesions, lymphocytic mastitis and diabetic mastopathy do not appear to be associated with an increased risk for lymphoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.